2007
DOI: 10.3310/hta11470
|View full text |Cite
|
Sign up to set email alerts
|

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model

Abstract: Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
106
0
7

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 89 publications
(117 citation statements)
references
References 49 publications
4
106
0
7
Order By: Relevance
“…In these studies it was not considered the type of device used, and it could be possible to anticipate values near the lower limit for the use of paracorporeal devices when comparing with implantable devices widely used in several centers worldwide. Similar values as those of mechanical support were observed for the use of cardiac resynchronization therapy defibrillator implantation combined with a systematic review that included data from more than 3,400 patients [24]. In parallel, a study about the isolated use of defibrillators in heart failure patients in our country showed a ratio of incremental cost-effectiveness of R $ 68,000.00 in the public and R $ 90,000.00 in the private sector [25].…”
supporting
confidence: 54%
“…In these studies it was not considered the type of device used, and it could be possible to anticipate values near the lower limit for the use of paracorporeal devices when comparing with implantable devices widely used in several centers worldwide. Similar values as those of mechanical support were observed for the use of cardiac resynchronization therapy defibrillator implantation combined with a systematic review that included data from more than 3,400 patients [24]. In parallel, a study about the isolated use of defibrillators in heart failure patients in our country showed a ratio of incremental cost-effectiveness of R $ 68,000.00 in the public and R $ 90,000.00 in the private sector [25].…”
supporting
confidence: 54%
“…For example, we have assumed the SE to be 0.1 of the mean value. 162,163 These bootstrapped simulations obtained from the PSA were used to construct cost-effectiveness acceptability curves (CEACs) to illustrate the effect of sampling uncertainty in which individual model parameters were sampled from the appropriate probability distribution. CEACs were presented to indicate the probability of a procedure being cost-effective using a willingness-to-pay threshold from £0 to £60,000.…”
Section: Measuring Cost-effectivenessmentioning
confidence: 99%
“…We used gamma distributions for costs (except for test costs that we assumed were fixed) and beta distributions for utility values and probabilities. 81 For the costs and probabilities in the model, we assumed that the standard error was 0.1 of the mean value 82,83 in order to calculate the alpha and beta values that are required for the probabilistic sensitivity analysis. These bootstrapped simulations were plotted on a cost-effectiveness plane and were used to present results as cost-effectiveness acceptability curves (CEACs), which indicated the probability of a GPP test being cost-effective compared with conventional testing using a willingness-to-pay threshold varying from £0 to £60,000.…”
Section: Measuring Cost-effectivenessmentioning
confidence: 99%